WallStreetZenWallStreetZen

NASDAQ: CNTX
Context Therapeutics Inc Earnings & Revenue

CNTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$21.3M
Current Profit Margin
0%

CNTX Return on Equity

Current Company
-136%
Current Industry
16.8%
Current Market
28.2%
CNTX's Return on Equity (-136%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CNTX announces earnings.

CNTX Return on Assets

Current Company
-109.5%
Current Industry
3.2%
CNTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CNTX Return on Capital Employed

Current Company
-252.55%
Current Industry
-42.4%
CNTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CNTX$0.00-$21.28M-$21.32MN/AN/A
QSI$1.29M-$85.96M-$91.82M+405.91%N/A
CLLS$12.13M-$8.00M-$65.34M-6.30%N/A
PDSB$0.00-$43.60M-$43.89MN/AN/A
CMPX$0.00-$43.57M-$45.44MN/AN/A

Context Therapeutics Earnings & Revenue FAQ

What were CNTX's earnings last quarter?

On Invalid Date, Context Therapeutics (NASDAQ: CNTX) reported Q1 2024 earnings per share (EPS) of -$0.23, up 42.5% year over year. Total Context Therapeutics earnings for the quarter were -$3.67 million. In the same quarter last year, Context Therapeutics's earnings per share (EPS) was -$0.40.

If you're new to stock investing, here's how to buy Context Therapeutics stock.

What was CNTX's earnings growth in the past year?

As of Q3 2024, Context Therapeutics's earnings has grown year over year. Context Therapeutics's earnings in the past year totalled -$21.32 million.

What was CNTX's revenue last quarter?

On Invalid Date, Context Therapeutics (NASDAQ: CNTX) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Context Therapeutics's revenue was $0.00.

What was CNTX's revenue growth in the past year?

As of Q3 2024, Context Therapeutics's revenue has grown null year over year. Context Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.